Skip to main content

Table 1 Baseline characteristics

From: Validation of administrative database codes for acute kidney injury in kidney transplant recipients

Total n = 524

 

Demographics

 

 Mean age (SD), years

57.7 (12.1)

Age (n (%))

 

 18 to <35

23 (4.4)

 35 to <60

262 (50)

 60 to <70

151 (28.8)

 ≥70

88 (16.8)

Women (n (%))

185 (35.3)

Race (n (%))

 

 Caucasian

374 (71.4)

 Asian

15 (2.9)

 Black

19 (3.6)

 Indian subcontinent

12 (2.3)

 Aboriginal

9 (1.7)

 Other

16 (3.1)

 Unknown

34 (6.5)

 Missing

45 (8.6)

Income quintile (n (%))

 

 One (lowest)

114 (21.8)

 Two

106 (20.2)

 Three

102 (19.5)

 Four

83 (15.8)

 Five (highest)

119 (22.7)

Rural location (n (%))

102 (19.5)

Year of cohort entry (n (%))

 

 2003–2006

149 (28.4)

 2007–2009

159 (30.4)

 2010–2012

216 (41.2)

Time since transplant, median (IQR), years

3.5 (1.5, 7.1)

Year of kidney transplant (n (%))

 

 1988–1992

18 (3.4)

 1993–1997

39 (7.45)

 1998–2002

147 (28.1)

 2003–2007

205 (39.1)

 2008–2012

115 (21.9)

Time on dialysis prior to transplant, median (IQR), years

2.0 (0.9, 3.5)

Time on dialysis prior to transplant (n (%)), years

 

 0 to <1

121 (23.1)

 1 to <2

118 (22.5)

 2 to <3

82 (15.7)

 3 to <4

57 (10.9)

 ≥4

98 (18.7)

Cause of end stage renal disease (n (%))

 

 Glomerulonephritis

148 (28.2)

 Hypertension

49 (9.4)

 Pyelonephritis/interstitial

35 (6.7)

 Cystic kidney disease

61 (11.6)

 Diabetes

108 (20.6)

 Other

29 (5.5)

 Unknown

94 (17.9)

Type of donor (n (%))

 

 Deceased

347 (66.2)

 Living

165 (31.5)

 Missing

12 (2.3)

Comorbidities (n (%))

 

 Coronary artery disease

156 (29.8)

 Diabetes

243 (46.4)

 Hypertension

489 (93.3)

 Congestive heart failure

88 (16.8)

 Chronic liver disease

36 (6.9)

 Chronic obstructive pulmonary disease

20 (3.8)

 Peripheral vascular disease

28 (5.3)

 Stroke/transient ischemic attack

12 (2.3)

Baseline laboratory measurements

 

 Serum creatinine, median (IQR), umol/L

133.0 (103.0, 173.9)

 eGFR, median (IQR), ml/min/1.73 m2a

46.1 (33.4, 62.8)

eGFR category (n (%)), ml/min/1.73 m2

 

 <15

21 (4.0)

 15 to <30

84 (16.0)

 30 to <45

146 (27.9)

 45 to <60

116 (22.1)

 ≥60

157 (30.0)

AKI definitions (n (%))b

 

 Any AKI

236 (45.0)

 AKIN stage 1

160 (30.5)

 AKIN stage 2

21 (4.0)

 AKIN stage 3

55 (10.5)

  1. aEstimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI equation [32]
  2. bDefined by serum creatinine